Type / Class
Equity / American Depositary Shares, each representing 1 Ordinary Shares
Shares outstanding
100M
Number of holders
28
Total 13F shares, excl. options
8.31M
Shares change
-3.45M
Total reported value, excl. options
$23.7M
Value change
-$5.59M
Number of buys
13
Number of sells
-9
Price
$2.85

Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2025

32 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2025.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.31M shares of 100M outstanding shares and own 8.28% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (4.12M shares), B Group, Inc. (3.28M shares), MACQUARIE GROUP LTD (227K shares), CITADEL ADVISORS LLC (222K shares), MORGAN STANLEY (87.7K shares), LPL Financial LLC (85.1K shares), MILLENNIUM MANAGEMENT LLC (57.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (53.9K shares), BNP PARIBAS FINANCIAL MARKETS (41.3K shares), and UBS Group AG (29.3K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.